Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹1,022.00
Market cap
₹2,145 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
32.3×Sector 47.3×
Promoter holding
63.31%+1.41% QoQ
FII holding
2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:19 IST BSE
Other Announcement

Windlas Biotech Other Announcement

Windlas Biotech submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms regulatory compliance with no material deviations noted.